{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T22:50:35Z","timestamp":1776293435571,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.jim.2010.09.013","type":"journal-article","created":{"date-parts":[[2010,9,23]],"date-time":"2010-09-23T08:24:52Z","timestamp":1285230292000},"page":"101-111","source":"Crossref","is-referenced-by-count":23,"title":["A novel homogeneous Biotin\u2013digoxigenin based assay for the detection of human anti-therapeutic antibodies in autoimmune serum"],"prefix":"10.1016","volume":"362","author":[{"given":"Zhihua Julia","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sock-Cheng","family":"Lewin-Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Good","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amena","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Quarmby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2010.09.013_bb0005","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00296-005-0085-0","article-title":"Demonstration of specific antibodies against infliximab induced during treatment of a patient with ankylosing spondylitis","volume":"26","author":"Aybay","year":"2006","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jim.2010.09.013_bb0010","doi-asserted-by":"crossref","first-page":"lb566","DOI":"10.1096\/fasebj.22.2_supplement.566","article-title":"Elimination of rheumatoid factor interference in immunoassays using the electrochemiluminescence (ECL) based Meso Scale Discovery (MSD) platform","volume":"22","author":"Bautista","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.jim.2010.09.013_bb0015","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0165-2478(93)90194-7","article-title":"Natural antibodies to avidin in human serum","volume":"35","author":"Bubb","year":"1993","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jim.2010.09.013_bb0020","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJMoa011931","article-title":"Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin","volume":"346","author":"Casadevall","year":"2002","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.jim.2010.09.013_bb0025","first-page":"495","article-title":"The serum digoxin concentration: ten questions to ask","volume":"56","author":"Cauffield","year":"1997","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.jim.2010.09.013_bb0030","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1164\/rccm.200312-1651OC","article-title":"Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma","volume":"170","author":"Djukanovic","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jim.2010.09.013_bb0035","first-page":"27","article-title":"Rheumatoid factor interference in immunological methods","volume":"26","author":"Hamilton","year":"1989","journal-title":"Monogr. Allergy"},{"key":"10.1016\/j.jim.2010.09.013_bb0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jim.2004.08.017","article-title":"Development and evaluation of a new ELISA for the detection and quantification of antierythropoietin antibodies in human sera","volume":"294","author":"Hoesel","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2010.09.013_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2008.01.001","article-title":"Recommendations on the risk-based strategies for detection and characterization of antibodies against biotechnology products","volume":"333","author":"Koren","year":"2008","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2010.09.013_bb0050","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1182\/blood.V100.10.3457","article-title":"Recombinant human thrombopoietin: basic biology and evaluation of clinical studies","volume":"100","author":"Kuter","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jim.2010.09.013_bb0055","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/clinchem\/37.3.411","article-title":"Use of chicken antibodies in enzyme immunoassays to avoid interference by rheumatoid factors","volume":"37","author":"Larsson","year":"1991","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jim.2010.09.013_bb0060","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.3382\/ps.0721807","article-title":"Chicken antibodies: taking advantage of evolution\u2014a review","volume":"72","author":"Larsson","year":"1993","journal-title":"Poult. Sci."},{"key":"10.1016\/j.jim.2010.09.013_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2004.06.002","article-title":"Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products","volume":"289","author":"Mire-Sluis","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2010.09.013_bb0070","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0022-2143(97)90187-6","article-title":"Serum concentrations of bisnorbiotin and biotin sulfoxide increase during both acute and chronic biotin supplementation","volume":"129","author":"Mock","year":"1997","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.jim.2010.09.013_bb0075","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/0091270005277075","article-title":"Population pharmacokinetics of Rituximab (Anti-CD20 Monoclonal Antibody) in rheumatoid arthritis patients during a Phase II clinical trial","volume":"45","author":"Ng","year":"2005","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jim.2010.09.013_bb0080","first-page":"172","article-title":"Immunogenicity of therapeutic monoclonal antibodies","volume":"5","author":"Pendley","year":"2003","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.jim.2010.09.013_bb0085","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1200\/JCO.20.3.719","article-title":"Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer","volume":"20","author":"Vogel","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jim.2010.09.013_bb0090","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/00365519009085803","article-title":"Endogenous interference in immunoassays in clinical chemistry","volume":"201","author":"Weber","year":"1990","journal-title":"Scand. J. Clin. Lab. Invest. Suppl."},{"key":"10.1016\/j.jim.2010.09.013_bb0095","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.4049\/jimmunol.139.9.2925","article-title":"Human monoclonal IgG rheumatoid factor has structural homology with bacterial Fc receptor proteins","volume":"139","author":"Weisbart","year":"1987","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2010.09.013_bb0100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ijc.23320","article-title":"Quantitation of HER2 and telomerase biomarkers in solid tumors with IgY antibodies and nanocrystal detection","volume":"122","author":"Xiao","year":"2008","journal-title":"Int. J. Cancer"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002217591000267X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002217591000267X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T12:51:45Z","timestamp":1685796705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002217591000267X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":20,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S002217591000267X"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2010.09.013","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}